Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Quantum Biopharma ( (TSE:QNTM) ).
Quantum Biopharma Ltd. released its unaudited condensed consolidated financial statements for the three and nine months ended September 30, 2025, showing a decrease in total assets from $17.1 million in 2024 to $14.2 million in 2025. The report highlights a significant increase in digital assets and a reduction in cash and cash equivalents, indicating a strategic shift in asset allocation. The financial results may impact the company’s operational strategies and stakeholder confidence.
More about Quantum Biopharma
Quantum Biopharma Ltd., formerly known as FSD Pharma Inc., operates in the biopharmaceutical industry. The company focuses on the development of innovative therapies and pharmaceutical products.
Average Trading Volume: 3,599
Technical Sentiment Signal: Sell
Current Market Cap: C$47.33M
Find detailed analytics on QNTM stock on TipRanks’ Stock Analysis page.